Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.11 USD | +0.53% | -1.45% | -25.28% |
15/05 | Earnings Flash (MRKR) MARKER THERAPEUTICS Reports Q1 Revenue $1.2M | MT |
30/04 | Ladenburg Thalmann Starts Marker Therapeutics With Buy Rating, $11 Price Target | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- MRKR Stock
- Revisions Marker Therapeutics, Inc.